EconPapers    
Economics at your fingertips  
 

RISKS TO THE RETURNS TO MEDICAL INNOVATION: THE CASE OF MYRIAD GENETICS

Jeffrey Clemens () and Stan Veuger ()

Contemporary Economic Policy, 2017, vol. 35, issue 2, 345-357

Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed

Downloads: (external link)
http://hdl.handle.net/10.1111/coep.12189 (text/html)
Access to full text is restricted to subscribers.

Related works:
Working Paper: Risks to the Returns to Medical Innovation: The Case of Myriad Genetics (2015) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:coecpo:v:35:y:2017:i:2:p:345-357

Ordering information: This journal article can be ordered from
http://www.blackwell ... bs.asp?ref=1074-3529

Access Statistics for this article

Contemporary Economic Policy is currently edited by Brad R. Humphreys

More articles in Contemporary Economic Policy from Western Economic Association International Contact information at EDIRC.
Bibliographic data for series maintained by Wiley Content Delivery ().

 
Page updated 2019-04-22
Handle: RePEc:bla:coecpo:v:35:y:2017:i:2:p:345-357